tiprankstipranks
Mereo Biopharma Group Plc (MREO)
NASDAQ:MREO
US Market

Mereo Biopharma Group Plc (MREO) Income Statement

Compare
602 Followers

Mereo Biopharma Group Plc Income Statement

Last quarter (Q3 2024), Mereo Biopharma Group Plc's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Mereo Biopharma Group Plc's net income was $-15.00M. See Mereo Biopharma Group Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 10.00M$ 1.51M$ 36.46M$ 393.00K$ -122.00K
Gross Profit
$ 7.43M$ 571.00K$ 18.56M$ -15.95M$ -23.73M
Operating Expenses
$ 35.84M$ 44.51M$ 39.49M$ 21.22M$ 15.91M
Depreciation and Amortization
$ 1.06M$ 1.51M$ 866.47K$ 44.00K$ 1.95M
EBITDA
$ -26.06M$ -42.06M$ -5.00M$ -37.52M$ -37.56M
Operating Income
$ -28.42M$ -43.57M$ -20.94M$ -37.57M$ -39.52M
Other Income/Expenses
$ -1.58M$ 7.48M$ 40.16M$ -129.27M$ -1.60M
Pretax Income
$ -30.00M$ -36.09M$ 14.24M$ -166.45M$ -41.12M
Net Income
$ -29.47M$ -34.20M$ 12.72M$ -163.63M$ -34.84M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -220.04$ -0.06$ 0.02$ -0.48$ -0.39
Diluted EPS
$ -220.04$ -0.06$ 0.02$ -0.48$ -0.39
Weighted Average Shares Outstanding
659.45M 603.20M 527.82M 337.72M 89.34M
Weighted Average Shares Outstanding (Diluted)
659.45M 603.20M 555.28M 338.95M 89.42M
Currency in USD

Mereo Biopharma Group Plc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis